|
Buprenorphine in the Treatment of Opioid Dependence |
|
| Home > Case Studies > Special Populations and the Use of Buprenorphine: Case Study Number 1 | |
Special Populations and the Use of Buprenorphine: Case Study Number 1A 27-year-old woman presents to your medical office on a Monday morning for a scheduled new patient appointment. She is 4 months pregnant and is seeking your help with care for this, her first pregnancy. She is generally healthy, smokes one pack of cigarettes a day, drinks occasional alcohol about once per month, and has a distant history of a motor vehicle accident that required a several-day stay in the hospital. She is on no medications and has no drug allergies. You have a general medical practice in a small, rural town. A mid-sized metropolitan area is about 75 miles away. Your practice has included the delivery of noncomplicated pregnancies at the local hospital, which has about 50 beds, and you have successfully treated four patients with buprenorphine in the office setting. However, two other patients you initially attempted to treat with buprenorphine eventually required referral to a methadone program in the city. The patient does not initially admit to drug use, but during questioning, she reports sniffing heroin, which she began using with her boyfriend about 6 months ago. This has been primarily on weekends, and she denies any injecting of drugs. (Physical examination shows no evidence of injecting.) She believes she can stop using heroin without any problem. However, she is a bit worried as she feels ill this day and thinks it is probably a cold or the pregnancy, but she also admits to being bothered with the idea that she should go home and use some heroin after she is finished meeting with you. During further questioning, she states that on rare occasions, she has snorted "just a touch" of heroin during the week to help her feel better. |
|
|
|
|
|
||
| Site Map | HHS Privacy Statement | Contact Us | Danya Learning Center | ||
| Developed by the American Academy of Addiction Psychiatry and Danya International with funding from the Center for Substance Abuse Treatment. | ||
| Last updated: September 20, 2002. | ||